PlasmaBound, an Irish medtech firm that has developed a new adhesive technology for medical devices, has secured a €3.1 million investment from BVP, Atlantic Bridge and HBAN's MedTech Syndicate,. The investment will be used to accelerate the commercialization of the company's technology, which has the potential to replace traditional adhesive methods and improve patient outcomes. PlasmaBound's technology uses cold plasma to bond materials, providing a strong and reliable bond that is also biocompatible and does not leave any residue. The investment will also support the expansion of the company's research and development team. Read more...